Induction of human CYP3A4 by huperzine A, ligustrazine and oridonin through pregnane X receptor-mediated pathways

By Zhang Yi-wen   Bao Mei-hua   Wang Guo   Qu Qiang   Zhou Hong-hao  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 7, 2014-07 ,pp. : 532-536

Govi-Verlag

Access to resources Recommend Favorite

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects

By Eap Chin   Buclin Thierry   Hustert Elisabeth   Bleiber Gabriela   Golay Kerry   Aubert Anne-Catherine   Baumann Pierre   Telenti Amalio   Kerb Reinhold  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 4, 2004-06 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite

Statin regulation of CYP3A4 and CYP3A5 expression

By Willrich Maria Alice Vieira   Hirata Mario Hiroyuki   Hirata Rosario Dominguez Crespo  

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 1017-1024

Future Medicine

Access to resources Recommend Favorite

Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43

By Krusekopf S.   Roots I.   Kleeberg U.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 7-12

Elsevier

Access to resources Recommend Favorite

Inhibitory metabolite complex formation of methylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D

By Delaforge M.   Jaouen M.   Bouille G.  

Environmental Toxicology and Pharmacology, Vol. 7, Iss. 3, 1999-07 ,pp. : 153-158

Elsevier

Access to resources Recommend Favorite